Preclinical Characterization of the Radioimmunoconjugate 111In or 90Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate-Reference-Cited by-同舟云学术

Preclinical Characterization of the Radioimmunoconjugate 111In or 90Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate

Published:2020-07-31 Issue:2 Volume:62 Page:232-239
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Funase Yuichi,Nakamura Eri,Kajita Masamichi,Saito Yasutaka,Oshikiri Shinobu,Kitano Michi,Tokura Masahiko,Hino Akihiro,Uehara Tomoya

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference30 articles.

1. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer

2. P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated withCDH3Promoter Hypomethylation

3. Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

4. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells

5. P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an â€œIntermediate/Metastableâ€ EMT State

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer;Expert Opinion on Drug Metabolism & Toxicology;2024-01-12

2. Antibody-drug Conjugate Targets, Drugs, and Linkers;Current Cancer Drug Targets;2022-07

3. Liposome-Encapsulated Tiancimycin A Is Active against Melanoma and Metastatic Breast Tumors: The Effect of cRGD Modification of the Liposomal Carrier and Tiancimycin A Dose on Drug Activity and Toxicity;Molecular Pharmaceutics;2022-03-15